TXG(10x Genomics, Inc.) 的内部人交易:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-11-10 | Saxonov Serge | Chief Executive Officer | 公开市场卖出 | 31,000 | $62.90 |
| 2026-09-22 | SULIMAN SHEHNAAZ | 董事 | 公开市场卖出 | 1,222 | $82.28 |
| 2026-09-22 | SULIMAN SHEHNAAZ | 董事 | 公开市场卖出 | 2,270 | $81.67 |
| 2026-09-22 | SULIMAN SHEHNAAZ | 董事 | 公开市场卖出 | 1,325 | $80.82 |
| 2026-09-22 | SULIMAN SHEHNAAZ | 董事 | 公开市场卖出 | 614 | $79.51 |
| 2026-09-22 | SULIMAN SHEHNAAZ | 董事 | 公开市场卖出 | 292 | $78.20 |
| 2026-09-22 | Saxonov Serge | Chief Executive Officer | 公开市场卖出 | 2,800 | $82.36 |
| 2026-09-22 | Saxonov Serge | Chief Executive Officer | 公开市场卖出 | 9,900 | $81.83 |
| 2026-09-22 | Saxonov Serge | Chief Executive Officer | 公开市场卖出 | 9,300 | $80.90 |
| 2026-09-22 | Saxonov Serge | Chief Executive Officer | 公开市场卖出 | 2,000 | $79.62 |
| 2026-09-22 | Saxonov Serge | Chief Executive Officer | 公开市场卖出 | 1,000 | $78.23 |
| 2026-09-09 | Taich Adam | Chief Financial Officer | 公开市场卖出 | 13,754 | $65.26 |
| 2026-09-09 | Taich Adam | Chief Financial Officer | 公开市场卖出 | 31,428 | $64.31 |
| 2026-09-09 | Taich Adam | Chief Financial Officer | 公开市场卖出 | 1,206 | $63.68 |
| 2026-09-03 | STUELPNAGEL JOHN R | 董事 | 公开市场卖出 | 6,174 | $62.61 |
| 2026-09-03 | STUELPNAGEL JOHN R | 董事 | 公开市场卖出 | 6,814 | $62.11 |
| 2026-09-03 | STUELPNAGEL JOHN R | 董事 | 公开市场卖出 | 7,012 | $60.66 |
| 2026-08-26 | Saxonov Serge | Chief Executive Officer | 公开市场卖出 | 492 | $64.75 |
| 2026-08-26 | Saxonov Serge | Chief Executive Officer | 公开市场卖出 | 6,494 | $63.98 |
| 2026-08-26 | Saxonov Serge | Chief Executive Officer | 公开市场卖出 | 3,500 | $63.02 |